# Treatment of Schizoaffective Disorder Using Mifepristone

> **NCT00725270** · PHASE2,PHASE3 · TERMINATED · sponsor: **Stanford University** · enrollment: 12 (actual)

## Conditions studied

- Psychotic Disorders
- Depressive Disorder, Major
- Depressive Disorder

## Interventions

- **DRUG:** Mifepristone
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT00725270
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1998-04
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Lack of funding.
- **Last updated:** 2017-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00725270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00725270, "Treatment of Schizoaffective Disorder Using Mifepristone". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00725270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*